Although SOCS3 exerted no remarkable effect on apoptosis, SOCS3 over-expression could enhance imatinib-induced apoptosis in CML cells. This evidence concerns the gene SOCS3 and chronic myelogenous leukemia, BCR-ABL1 positive.